---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-006234"
form_type: "8-K"
ticker: "RXST"
cik: "0001111485"
company_name: "RxSight, Inc."
filed_at: "2023-03-06T23:59:59+00:00"
generated_at: "2026-06-18T11:08:31.278882+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# RxSight Q4 revenue $16.1M (+91% YoY); FY22 revenue $49.0M (+117%); guides FY23 rev $78-83M

## Summary
- Q4 2022 revenue $16.1M, up 91% YoY; LAL procedure volumes up 208% to 9,123 units; LDD installed base 400 (+94% YoY).
- Full year 2022 revenue $49.0M, up 117% YoY; sold 195 LDDs and 25,284 LALs.
- FY23 revenue guidance $78-83M (59-69% growth); gross margin guidance 52-54% (up from 43.5% in FY22).
- Net loss Q4 $(15.6)M ($0.56 loss per share); adjusted net loss $(12.6)M ($0.45 loss per share).
- Completed public offering of 4.6M shares (including underwriter option) at $12.50/share in Feb 2023, raising ~$57.5M gross.

## SEC filing metadata
- accession: 0000950170-23-006234
- form_type: 8-K
- ticker: RXST
- cik: 0001111485
- company_name: RxSight, Inc.
- filed_at: 2023-03-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1111485/000095017023006234/0000950170-23-006234-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1111485/000095017023006234/rxst-20230306.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-006234
- JSON: https://secwatch.observer/filing/0000950170-23-006234.json
- Plain text: https://secwatch.observer/filing/0000950170-23-006234.txt

## Key facts
- Earnings Releases
  RxSight, Inc. reported the three and twelve-months ended December 31, 2022 results: revenue $16.1 million, net income $(15.6) million, EPS $(0.56) per basic and diluted share. Guidance initiated.
  - Period: the three and twelve-months ended December 31, 2022
  - Revenue: $16.1 million
  - Net income: $(15.6) million
  - EPS: $(0.56) per basic and diluted share
  - Guidance: initiated
  - Result: reported results
  source text: today reported financial results for the three months and full year ended December 31, 2022. Key Quarterly and Full Year Highlights • Recognized fourth quarter 2022 revenue of $16.1 million, an increase of 91% compared to the fourth quarter of 2021, reflecting: • The sale of 57 Light Delivery Devices (LDDTMs), representing a 27% unit increase from the fourth quarter
  evidence_url: https://www.sec.gov/Archives/edgar/data/1111485/000095017023006234/0000950170-23-006234-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.